TG Therapeutics | TGTX - 자산





자산 변화 날짜
AbbVie USD 133.96B 62M 2025-12
Alaunos Therapeutics USD 2.97M 758K 2025-12
Amgen USD 92.5B 1.92B 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Arrowhead Research USD 1.6B 218.89M 2025-12
Bayer EUR 104.54B 331M 2025-12
Biogen USD 29.48B 43.6M 2026-03
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Curis USD 19.97M 9.27M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
J&J USD 200.89B 1.68B 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Novavax USD 1.18B 3.38M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Verastem USD 246.44M 69.59M 2025-12
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03